Keith A. Jenkins, N.P.; Decision and Order, 35339-35345 [2021-14163]
Download as PDF
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–14210 Filed 7–1–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 19–22]
Keith A. Jenkins, N.P.; Decision and
Order
On February 19, 2020, the Drug
Enforcement Administration
(hereinafter, DEA or Government)
Administrative Law Judge Mark M.
Dowd (hereinafter, ALJ), issued a
Recommended Rulings, Findings of
Fact, Conclusions of Law, and Decision
(hereinafter, RD) on the action to revoke
the DEA Certificate of Registration
Numbers MJ3401609 and MJ4509331 of
Keith A. Jenkins, N.P. The ALJ
transmitted the record to me on March
10, 2020. Having reviewed and
considered the entire administrative
record before me, I adopt the ALJ’s RD
with modifications, where noted
herein.*A
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby dismiss the Order to
Show Cause issued to Keith A. Jenkins,
N.P. I further order that any pending
applications for renewal of DEA
Certificates of Registration MJ3401609
and MJ4509331 be granted. This Order
is effective immediately.
D. Christopher Evans,
Acting Administrator.
Paul Soeffing, Esq., for the Government
Robert W. Liles, Esq. and Meaghan K.
McCormick, Esq., for the Respondent
lotter on DSK11XQN23PROD with NOTICES1
Recommended Rulings, Findings of
Fact, Conclusions of Law, and Decision
of the Administrative Law Judge
The Assistant Administrator,
Diversion Control Division, Drug
Enforcement Administration (DEA),
*A I have made minor, nonsubstantive,
grammatical changes to the RD. Where I have made
any substantive changes, omitted language for
brevity or relevance, or where I have added to or
modified the ALJ’s opinion, I have bracketed the
modified language and explained the edit in a
footnote marked with an asterisk and a letter in
alphabetical order.
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
issued an Order to Show Cause (OSC),1
dated April 23, 2019, seeking to revoke
the Respondent’s Certificates of
Registration (COR), numbers
‘‘MJ3401609 and MJ4509331, pursuant
to 21 U.S.C. 824(a)(5), and deny any
applications for renewal or modification
of such registration and any
applications for any other DEA
registrations pursuant to 21 U.S.C.
824(a)(5),’’ because the Respondent has
been excluded from participation in a
program pursuant to section 1320a–7(a)
of Title 42. OSC, at 1. The Respondent
requested a hearing on May 16, 2019,2
and prehearing proceedings were
initiated.3 A hearing was conducted in
this matter on November 20, 2019, at the
DEA Hearing Facility in Arlington,
Virginia.
The issue ultimately to be adjudicated
by the Acting Administrator, with the
assistance of this recommended
decision, is whether the record as a
whole establishes by a preponderance of
the evidence that the Respondent’s
subject registration with the DEA should
be revoked pursuant to 21 U.S.C.
824(a)(5).
After carefully considering the
testimony elicited at the hearing, the
admitted exhibits, the arguments of
counsel, and the record as a whole, I
have set forth my recommended
findings of fact and conclusions of law
below.
The Allegations
In the OSC, the Government contends
that the DEA should revoke the
Respondent’s DEA COR because he has
been excluded from participation in a
program pursuant to section 1320a–7(a)
of Title 42.
Specifically, the Government alleges
the following:
1. Respondent is registered with the
DEA as an MLP-nurse practitioner in
Schedules II through V under DEA
Certificate of Registration MJ3401609, at
105 Vanner Rd., Mt. Juliet, TN 37122.
Respondent is also registered with the
DEA under DEA Certificate of
Registration MJ4509331, at 3909
Woodley Rd., Toledo, OH 43606, with a
mailing address of 105 Vanner Rd., Mt.
Juliet, TN 37122. Respondent’s
registrations both expire by their terms
on December 31, 2020. Id. Prior to the
current action, Respondent’s DEA
Certificates of Registration have not
been the subject of disciplinary or other
adverse action by the DEA.
2. On August 7, 2017, Respondent
entered an ‘‘Alford Plea of Guilty to a
PO 00000
1 ALJ
Ex. 1.
Ex. 2.
3 ALJ Ex. 3.
2 ALJ
Frm 00081
Fmt 4703
Sfmt 4703
35339
Felony’’ to the offense of ‘‘False
Statement to Medicaid.’’ On August 1l,
2017, the Circuit Court of Fairfax
County, Virginia entered its sentencing
Order for Respondent’s offense of ‘‘False
Statement for Payment (F)’’ in violation
of Va. Code Section 32.1–314(F) FRD
3337F9. See Commonwealth of Virginia
v. Keith Allen Jenkins, No. FE–2017–
0000711 (Fairfax Cty. Cir. Ct.).
3. Based on Respondent’s conviction,
the U.S. Department of Health and
Human Services, Office of Inspector
General (‘‘HHS/OIG’’), by letter dated
February 28, 2018, mandatorily
excluded Respondent from participation
in Medicare, Medicaid and all federal
health care programs for a minimum
period of five years pursuant to 42
U.S.C. 1320a–7(a), effective March 20,
2018. Notwithstanding the fact that the
underlying conduct for which the
Respondent was convicted had no
nexus to controlled substances, the
Respondent’s mandatory exclusion from
Medicare, Medicaid, and all federal
health care programs by HHS/OIG
warrants revocation of the Respondent’s
registration pursuant to 21 U.S.C.
824(a)(5). See, e.g., Richard Hauser,
M.D., 83 FR 26308 (2018).
The Hearing
Government’s Opening Statement
The Government outlined its case in
its Opening Statement. The Government
seeks the revocation of the Respondent’s
registrations pursuant to 21 U.S.C.
824(a)(5), as the Respondent has been
excluded from a program pursuant to
§ 1320a–7a of Title 2. Tr. 12. The
Government explained that in 2017, the
Respondent entered an Alford plea of
guilty, to the felony offense of false
statement to Medicaid, in the Circuit
Court of Fairfax County, Virginia. On
the basis of that conviction, in 2018, the
Department of Health and Human
Resources, Office of Inspector General
mandatorily excluded the Respondent
from participation in Medicare,
Medicaid and all federal health care
programs pursuant to 42 U.S.C. 1320a7(a). The Respondent’s exclusion
remains in effect. Id.
Respondent’s Opening Statement
In his Opening Statement, the
Respondent noted he has stipulated to
all of the operative facts of the case. Id.
at 13. The Respondent conceded he was
convicted as charged, he was excluded
from participation from Medicare,
Medicaid and all federal health benefit
programs, as alleged. Acknowledging
the evidentiary burden shift to him,
upon the prima facie showing of these
facts, the Respondent argued that his
E:\FR\FM\02JYN1.SGM
02JYN1
35340
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
Registrations should not be revoked as
that would be inconsistent with the
public interest. The Respondent argued
that he has accepted responsibility for
his misconduct, and further that this
type of conduct can no longer reoccur,
as preventive safeguards are now in
place.
Referring to the five operative factors
under § 823(f), the Respondent noted
that the Respondent has the ‘‘backing
and support’’ of the state nursing
boards. Id. at 14. He is knowledgeable
and experienced with respect to
controlled substances. He has never
been accused of any violation, state or
federal, of controlled substance statutes.
He has always complied with these
statutes. Finally, there is no evidence
that any of his ‘‘other conduct’’ could be
a threat to the public safety. Thus, in
balancing the five factors under § 823(f),
the retention of his registrations would
not be inconsistent with the public
interest. Id. at 15.
Government’s Case in Chief
Before presenting witnesses, the
Government offered the sworn and
notarized COR history for the
Respondent, which was admitted
without objection. See GX 1. The
Government otherwise presented its
case in chief through the testimony of a
single witness. The Government
presented the testimony of a Diversion
Investigator.
lotter on DSK11XQN23PROD with NOTICES1
Diversion Investigator (DI)
The DI has worked for the Drug
Enforcement Administration for five
and a half years and holds a Bachelor’s
Degree in Accounting and a Master’s
Degree in Business Administration. Tr.
16–17. She has graduated from the 12week Basic Diversion Investigator
School. Id. at 17. She has also received
advanced diversion investigator
training, tactical diversion training, and
asset forfeiture training. Id. at 18.
The instant investigation commenced
when the DEA learned that the
Respondent’s Tennessee Nursing license
had been suspended by the Tennessee
Board of Nursing. Id. The DI later
learned that the Respondent had been
excluded from Medicare, Medicaid and
all other federal health care programs by
HHS/OIG. The DI obtained a copy of the
Respondent’s Alford plea of guilty to the
Virginia felony offense of False
Statement to Medicaid, a copy of the
sentencing order and a copy of the
Respondent’s exclusion letter by HHS/
OIG. Id. at 19–22; GX 3, 4, 5. The DI
verified the Respondent’s exclusion by
accessing the HHS website. Tr. 23; GX
6. The DI confirmed on the HHS website
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
the exclusion remained active as of the
day of the hearing. Tr. 24.
On cross-examination, the DI
conceded the instant case did not
involve the diversion of controlled
substance, nor was she aware of any
such violations by the Respondent. Id.
at 24–25.
Respondent’s Case in Chief
Keith A. Jenkins, N.P.
The Respondent, Keith A. Jenkins, is
a licensed Advanced Practice Registered
Nurse in Tennessee and Ohio. Id. at 33;
RX 1, 7. He holds DEA registrations in
Tennessee and Ohio. Tr. 33, 39–40; RX
4. Other than this instant proceeding,
the Respondent has never been
disciplined or cautioned by the DEA. Tr.
39, 61. The Respondent has never been
admonished, reprimanded or
disciplined by any of the state nursing
boards regarding his prescribing
practices. Id. at 61. The Respondent has
never been convicted of any offense
involving controlled substances. Id.
His educational background includes
an Associate’s Degree in Medical
Laboratory Technology from
Cumberland College in 1997, an
Associate’s Degree in Nursing in 2002,
a Master’s Degree in Nursing and Adult
Bariatric Nurse Practitioner in 2014,
post-Master’s Certificate for Family
Nurse Practitioner in 2015, and postMaster’s Certificate for Psychiatric
Nurse Practitioner in 2017. Id. at 28.
The Respondent is currently working on
his Doctorate, which he expects to
complete by January 2020.
The Respondent is an adjunct faculty
member in a nurse practitioner program.
Id. at 28–29; RX 1. He teaches various
courses, including Pharmacology. Tr.
41. He works part-time at two clinics, a
bariatric clinic, and a primary care
psychiatric clinic. Id. at 29. The
Respondent typically prescribed
controlled substances, Phentermine and
Qsymia. At the psychiatric clinic,
controlled substances typically
prescribed include benzodiazepines,
such as Clonazepam. Other controlled
substances prescribed there include
Alprazolam, Ritalin, and Adderall. Id. at
30. The Respondent also volunteers at a
free clinic and may prescribe, on
average, one opioid per month. Id. at 31,
80.
The Respondent reported taking
precautions in prescribing controlled
substances, including checking the state
database for patient drug use pattern or
use history. Id. at 32. Additionally, he
requires drug screens if warranted by
the results of the database inquiry, as
well as randomly. To remain current
with obligations regarding prescribing
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
controlled substances, the Respondent
reported that he attends at least two
medical conferences per year, a number
of continuing education courses, and
receives regulatory updates. Id. at 41,
44; RX 9, 10, 11. His adjunct faculty
position also requires him to stay
current with prescribing protocol.
The Respondent’s Ohio APRN
includes the authority to prescribe
controlled substances. Tr. 34; RX 7. At
the time of the hearing, the
Respondent’s authority to prescribe in
Ohio was unrestricted. However, the
Respondent’s Tennessee license
reflected the disciplinary action of
probation, requiring some continuing
education as a result of the Virginia
state court conviction. Tr. 36; RX 8. The
Respondent has completed the required
continuing education. Tr. 42–43; RX 9,
10, 11. His Tennessee prescribing
authority remained unrestricted. Tr. 36,
60. In September 2019, despite
disclosing the circumstances
surrounding his Virginia conviction, the
Respondent obtained South Carolina
nursing licensure. Id. at 37–38; RX 12.
He retains unrestricted prescribing
authority in South Carolina. Tr. 38.
As relates to the Respondent’s
underlying misconduct, the Respondent
worked for Actera Home Health from
2008–2015, as Administrator. Id. at 45.
He did not generally provide any
clinical support or prescribe
medication. Id.
His employment there ended as a
result of an audit by state authorities.
The mother of a child patient of the
home health service was found to be
abusing medication. Id. at 46. In
response to actions by the service, the
mother filed a complaint with state
regulators against the home health
service, resulting in an investigation and
audit. Id. Although the investigation
revealed no wrongdoing by the service,
the audit disclosed a billing
discrepancy. A different child patient
was signed up for ‘‘personal care’’
services. Id. at 47, 71, 73–74. The
service used an Electronic Medical
Record system (EMR) to maintain
treatment records and to bill for
services. The Respondent explained that
the service’s EMR system could not
directly bill Medicaid, so the service
used a secondary billing system to bill
Medicaid, which auto billed weekly. Id.
at 48, 70. The secondary billing system
would automatically ‘‘pull claims over’’
to it from the EMR. Id. at 48, 70–71.
Services for this child were initiated
and reported in the EMR system, which
automatically initiated the Medicaid
billing through the secondary billing
system. Id. at 48, 71, 78. The normal
checks and balances within the home
E:\FR\FM\02JYN1.SGM
02JYN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
health service involved squaring the
care-giver service reports with the
billing. Id. at 49, 72. If the caregiver
reported a cessation of care or change in
care, the billing would be ceased or
adjusted to reflect that. Id. at 78–79.
However, in this case, the grandmother/
custodian refused to allow care-givers to
provide any care at all. As there were no
care-giver reports generated, the billing
to Medicaid continued automatically.
There were no care-giver reports to
prompt the review of that patient’s
billing to Medicaid, [so the audit
safeguards never caught the error.] Id. at
49, 74–76, 78. The overpayment from
Medicaid was approximately $80,000.
Id. at 48. When the audit revealed this
overpayment, Medicaid audited every
patient the service billed Medicaid. No
other discrepancies were discovered. Id.
at 53, 78.
The Respondent entered an Alford
plea of guilty to false statement to
Medicaid. Id. at 50, 52. The Respondent
understood at the time of his plea that,
as Administrator of the home health
service, he was ‘‘responsible’’ for the
improper claims to Medicaid, despite
that he did not personally enter the
claims. Id. at 50, 69. His sentence was
three years suspended, three years
inactive probation, and $83,027.56 in
restitution. Id. at 51–52, 63. I asked the
Respondent if he realized, at the time he
plead guilty, the criminal offense of
false statement to Medicaid required the
intent of intentional or willful. The
Respondent reported that his criminal
attorney handled the plea negotiation
and recommended the Respondent view
the guilty plea as a ‘‘business decision.’’
Id. at 68–69. [Respondent stated, ‘‘Since
they never got a record on him, it never
got caught. In hindsight, it was a huge
gap on our end or my end, really, that
let that slip through.’’ Id. at 49. His
attorney asked, ‘‘So whose fault was it?’’
Id. ‘‘Well, mine.’’ Id.]
Conceding the Government proved its
prima facie case, the Respondent argued
that he should be permitted to keep his
CORs. Id. at 57. He explained that the
incident that gave rise to the felony
conviction and the resultant HHS
exclusion was [‘‘an isolated incident, it
wasn’t intentional but [he does] realize
that in [his] acting role as administrator,
ultimately, it is [his] responsibility.’’] Id.
at 58, 67. The Respondent did not have
clinical duties at the service. He did not
supervise the line care providers. They
were supervised by the nursing director.
Id. at 77–78. Although he had access to
the billing records in the form of an
electronic report, his duties did not
include reviewing the accuracy of the
billing report. Id. at 78. The accuracy of
the billing was insured by periodic
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
audits, which failed them in this case.
Id. The Respondent did not benefit from
the overpayment,*B other than his
salary.
For his Tennessee APRN, a physician
supervisor is required. Id. at 59. The
Respondent has a physician supervisor
at each clinic where he works. Id. at 63–
64. Although supervision is required
once a month, he works closely with his
physician supervisor and sees him
weekly. The supervisor critically
reviews patient charts and must sign off
on each controlled substance
prescription. Id. at 59. The Respondent
reported that his supervisors have yet to
reject any of the Respondent’s
prescriptions. Id. at 65.
The Respondent reported that he has
not used his Ohio nursing license. He
has not worked in Ohio. Id. at 66.
The Respondent stated he remains
fully compliant with state and federal
controlled substance laws and
regulations. Id. at 61. The Respondent
noted he was an infrequent prescriber of
controlled substances. Id. The
Respondent believed it is in the public
interest for him to retain his
registrations.
The Facts
Stipulations of Fact
The Government and the Respondent
have agreed to each of the following
stipulations, which I recommend be
accepted as fact in these proceedings:
1. Respondent is registered with the
DEA as a MLP-nurse practitioner in
Schedules II through V under DEA
Certificate of Registration MJ3401609 at
105 Vanner Rd., Mt. Juliet, TN 37122.
Respondent is also registered with the
DEA under DEA Certificate of
Registration MJ4509331 at 3909
Woodley Rd., Toledo, OH 43606, with a
mailing address of 105 Vanner Rd., Mt.
Juliet, TN 37122. Respondent’s
registrations both expire by their terms
on December 31, 2020. Prior to the
current action, Respondent’s DEA
Certificates of Registration have not
been the subject to disciplinary or other
adverse action by the DEA.
2. From 2006 to 2013, Respondent
worked in an administrative, nonclinical, capacity for a Virginia-based
home health agency. While employed at
the home health agency, the agency was
audited by state Medicaid authorities
and Respondent’s role in the billing of
claims for a specific patient were
investigated by the state. On August 7,
2017, Respondent entered an ‘‘Alford
Plea of Guilty to a Felony’’ to the offense
*B This fact seems to be reasonably inferred from
the record. The clinic paid restitution ‘‘immediately
once it was identified.’’ Tr. 52.
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
35341
of ‘‘False Statement to Medicaid.’’ On
August 11, 2017, the Circuit Court of
Fairfax County, Virginia, entered its
sentencing Order for Respondent’s
offense of ‘‘False Statement of
Payment(F)’’ in violation of Va. Code
Section 32.1–314(F) FRD3337F9.
Commonwealth of Virginia v. Keith
Allen Jenkins, No. FE–2017–0000711
(Fairfax Cty. Cir. Ct.). Mr. Jenkins was
sentenced to ‘‘3 years w/all 3 years
suspended.’’ Furthermore, the Court
Ordered that all ‘‘3 years [were subject
to] inactive probation.’’ Simply put, Mr.
Jenkins was not incarcerated, nor is he
required to report to a Probation Officer
during the period of his 3-year
suspended sentence.
3. Based on Respondent’s conviction,
the U.S. Department of Health and
Human Services, Office of Inspector
General (‘‘HHS/OIG’’), by letter dated
February 28, 2018, mandatorily
excluded Respondent from participation
in Medicare, Medicaid and all federal
health care programs for a minimum
period of five years pursuant to 42
U.S.C. 1320a–7(a), effective March 20,
2018.
4. Reinstatement of eligibility to
participate in Medicare, Medicaid and
all federal health care programs after
exclusion by HHS/OIG is not automatic.
5. Respondent is currently excluded
from participation in Medicare,
Medicaid and all federal health care
programs.
6. Restitution in the amount of
$83,027.56 to the Medicaid program was
ordered by the Court. The restitution
was paid in full by the time of
Respondent’s Alford Plea filing.
7. On April 23, 2019, the Assistant
Administrator, Diversion Control
Division, DEA, issued an Order to Show
Cause to Respondent, giving
Respondent notice of an opportunity to
show cause why the DEA should not
revoke Respondent’s DEA Certificates of
Registration Nos. MJ3401609
(Tennessee) and MJ4509331 (Ohio),
pursuant to 21 U.S.C. 824(a)(5), and
deny any pending application(s) as a
practitioner for registration in Schedules
II through V, alleging that Respondent
has been excluded from participation in
all federal health care programs as
defined in 21 U.S.C. 824(a)(5).
8. On May 16, 2019, Respondent,
through his legal counsel, filed a timely
request for administrative hearing in the
Matter of Keith A. Jenkins, N.P.
9. On May 17, 2019, the
Administrative Law Judge (ALJ)
assigned to this case issued the Court’s
Order for Prehearing Statements to the
DEA and Respondent.
10. On May 29, 2019, counsel for the
Government filed the Government’s
E:\FR\FM\02JYN1.SGM
02JYN1
35342
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Prehearing Statement. Concurrent with
this filing, counsel also filed the
Government’s Motion for Summary
Disposition.
11. On May 30, 2019, Respondent
filed an Unopposed Motion for
Extension of Time to Submit
Respondent’s Prehearing Statement and
Respondent’s Response to the
Government’s Motion for Summary
Disposition.
12. On May 31, 2019, the Court issued
its Order Granting Respondent’s
Unopposed Motion for Extension of
Time until June 21, 2019 at 2:00 p.m.
EST.
13. Respondent is currently licensed
by the Ohio Board of Nursing to practice
as an Advanced Practice Registered
Nurse (APRN), license number
APRN.CNP.021771. The Respondent’s
Ohio APRN license includes the
authority to prescribe.
14. Respondent is currently licensed
by the Tennessee Board of Nursing to
practice as an Advanced Practice
Registered Nurse, license no. 19606.
Respondent’s Tennessee APRN license
is currently on probation but is
unrestricted.
15. At this time, Respondent’s DEA
Certificates of Registration in Ohio and
Tennessee are active and he is
authorized to prescribe controlled
substances in Schedules II through V.
Findings of Fact
The factual findings below are based
on a preponderance of the evidence,
including the detailed, credible, and
competent testimony of the
aforementioned witnesses, the exhibits
entered into evidence, and the record
before me.
1. Respondent is registered with the
DEA as a MLP-nurse practitioner in
Schedules II through V under DEA
Certificate of Registration MJ3401609 at
105 Vanner Rd., Mt. Juliet, TN 37122.
Respondent is also registered with the
DEA under DEA Certificate of
Registration MJ4509331 at 3909
Woodley Rd., Toledo, OH 43606, with a
mailing address of 105 Vanner Rd., Mt.
Juliet, TN 37122. Stipulation (‘‘Stip.’’) l;
ALJ Ex. 13 at 10. Respondent’s
registrations both expire by their terms
on December 31, 2020. Id. Prior to the
current action, Respondent’s DEA
Certificates of Registration have not
been the subject of disciplinary or other
adverse action by the DEA. Id.
2. On August 7, 2017, Respondent
entered an ‘‘Alford Plea of Guilty to a
Felony’’ to the offense of ‘‘False
Statement to Medicaid.’’ Stip. 2; ALJ Ex.
13 at 10. On August 11, 2017, the
Circuit Court of Fairfax County,
Virginia, entered its sentencing Order
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
for Respondent’s offense of ‘‘False
Statement for Payment (F)’’ in violation
of Va. Code Section 32.1–314(F)
FRD3337F9. See Commonwealth of
Virginia v. Keith Allen Jenkins, No. FE–
2017–0000711 (Fairfax Cty. Cir. Ct.).
3. Based on Respondent’s conviction,
the U.S. Department of Health and
Human Services, Office of Inspector
General (‘‘HHS/OIG’’), by letter dated
February 28, 2018, mandatorily
excluded Respondent from participation
in Medicare, Medicaid and all federal
health care programs for a minimum
period of five years pursuant to 42
U.S.C. 1320a–7(a), effective March 20,
2018. Stip. 3; ALJ Ex. 13 at 10–11.
4. Reinstatement of eligibility to
participate in Medicare, Medicaid and
all federal health care programs after
exclusion by HHS/OIG is not automatic.
Stip. 4; ALJ Ex. 13 at 11.
5. Respondent is currently excluded
from participation in Medicare,
Medicaid and all federal health care
programs. Stip. 5; ALJ Ex. 13 at 11.
6. Restitution in the amount of
$83,027.56 to the Medicaid program was
ordered by the Court. Stip. 6; ALJ Ex.
13, at 11.
7. On April 23, 2019, the Assistant
Administrator, Diversion Control
Division, DEA issued an Order to Show
Cause to Respondent, giving
Respondent notice of an opportunity to
show cause why the DEA should not
revoke Respondent’s DEA Certificates of
Registration Nos. MJ3401609
(Tennessee) and MJ4509331 (Ohio),
pursuant to 21 U.S.C. 824(a)(5), and
deny any pending application(s) as a
practitioner for registration in Schedules
II through V, alleging that Respondent
has been excluded from participation in
all federal health care programs as
defined in 21 U.S.C. 824(a)(5). Stip. 7;
ALJ Ex. 13 at 11.
8. On May 16, 2019, Respondent,
through his legal counsel, filed a timely
request for administrative hearing in the
Matter of Keith A. Jenkins, N.P. Stip. 8;
ALJ Ex. 13 at 11.
9. On May 17, 2019, the
Administrative Law Judge (ALJ)
assigned to this case issued the Court’s
Order for Prehearing Statements to the
DEA and Respondent. Stip. 9; ALJ Ex.
13 at 11.
10. On May 29, 2019, counsel for the
Government filed the Government’s
Prehearing Statement. Stip. 10; ALJ Ex.
13 at 11. Concurrent with this filing,
counsel also filed the Government’s
Motion for Summary Disposition. Id.
11. Respondent is currently licensed
by the Ohio Board of Nursing to practice
as an Advanced Practice Nurse (APRN),
license number APRN.CNP.021771.
Stip. 13; ALJ Ex. 13 at 12.
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
12. The Respondent’s Ohio APRN
license includes authority to prescribe.
Id.
13. Respondent is currently licensed
by the Tennessee Board of Nursing to
practice as an Advanced Practice
Registered Nurse, license no. 19606.
Stip. 14; ALJ Ex. 13 at 12. Respondent’s
Tennessee APRN license is currently on
probation but is unrestricted. Id.
14. At this time, Respondent’s DEA
Certificates of Registration in Ohio and
Tennessee are active and he is
authorized to prescribe controlled
substances in Schedules II through V.
Stip. 15; ALJ Ex. 13 at 12.
15. Respondent testified that he works
at a bariatric clinic where he
predominately treats morbid obesity and
typically prescribes Phentermine and
Qsymia to those patients. Tr. 29.
16. He also works at a primary
behavioral health clinic where he treats
depression, anxiety, schizophrenia,
bipolar disorder, personality disorders,
and substance abuse disorders and
prescribes benzodiazepines such as
Clonazepam and Alprazolam, as well as
stimulants such as Ritalin and Adderall.
Id. at 30.
17. Respondent testified that at both
the bariatric clinic and the behavioral
health practice where he works, drug
screens are performed to ensure that
diversion doesn’t occur. Id. at 32.
18. Respondent testified that although
he holds two DEA Certificates of
Registration, he does not use his
registration for Ohio. Id. at 39.
19. Respondent testified that to
remain current in his knowledge of, and
obligations with respect to, controlled
substances and prescribing he attends
conferences and takes continuing
education. Id. at 41–42; RX 9; RX 11.
20. Respondent testified that from
2008 to 2015 he worked at Actera Home
Health, which was a home health
agency that provided skilled care,
private duty and personal care. Tr. 45.
21. Respondent testified that he did
not generally provide clinical support at
Actera Home Health, nor did he write
prescriptions there. Id.
22. Respondent testified that the
mother of a child receiving services at
Actera Home Health lodged a complaint
against Actera Home Health. Id. at 46.
23. Respondent testified that the
complaint was not substantiated. Id.
24. During investigation of the
complaint by the state of Virginia a
billing error was discovered for a
different patient. Id. at 46, 71.
25. Respondent testified that the
billing error was an overpayment of
approximately $80,000. Id. at 48.
26. Respondent testified that the
service’s billing checks-and-balance
E:\FR\FM\02JYN1.SGM
02JYN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
system failed to disclose an improper
billing to Medicaid. Once the initiation
of a patient’s treatment is entered into
the Electronic Medical Record (EMR),
which triggers automatic billing, in this
case to Medicaid, that billing continues
until a treatment report noting cessation
of treatment triggers the termination of
billing. Here, the patient’s guardian
refused treatment for the patient. So, no
treatment reports were ever generated
and automatic billing to Medicaid
continued, despite no treatment being
provided. Id. at 48, 71, 74.
27. Respondent testified that ‘‘it was
a huge gap on our end or my end, really,
that let that slip through.’’ Id. at 49.
28. Respondent testified that the fault
was ‘‘mine’’ and that it was ‘‘my
responsibility.’’ Id.
29. Respondent testified that he
entered an Alford plea regarding this
incident. Id. at 29; GX 3.
30. Respondent testified that he
entered the Alford plea because ‘‘I did
not personally go enter these claims, but
I am responsible for it as the
administrator.’’ Tr. 50.
31. Respondent testified that he was
sentenced to three years, but it was
suspended and he served no time in jail.
Id. at 51.
32. Respondent testified that he was
put on probation for three years, which
remains in effect for another year. Id. at
51–52.
33. Respondent testified that the
clinic paid restitution of $83,027.67. Id.
at 42; GX 3.
34. Respondent testified that his
Alford plea resulted in his conviction of
a felony for a ‘‘false statement to
Medicaid.’’ Tr. 52.
35. Respondent testified that he was
excluded by the HHS/OIG from
Medicare and Medicaid. Id. at 54, 57;
GX 5.
36. Respondent testified that his false
statement to Medicaid ‘‘was an isolated
incident,’’ ‘‘wasn’t intentional’’ but that
as administrator ‘‘it is my
responsibility.’’ Tr. 58.
37. Respondent testified that ‘‘[t]he
Board of Nursing did not deem me a
threat to public welfare and safety’’ and
that he has ‘‘no criminal background at
all with substances.’’ Id.
38. Respondent testified that he
‘‘absolutely’’ accepts responsibility for
the misconduct. Id. at 58, 67.
39. Respondent testified that he
considers his criminal conviction to be
a serious violation. Id. at 67.
40. Respondent testified that he is
remorseful for his violation. Id. at 58,
67.
41. Respondent testified that this
violation will not happen again because
he no longer works in administrative
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
roles, but instead provides direct patient
care and does no billing. Id. at 58.
42. Respondent testified that he also
has a physician supervisor who
provides oversight. Id. at 58–59.
Respondent testified that, under
Tennessee law, his physician supervisor
must sign off on every controlled
substance prescription that he writes.
Id. at 59, 65.
43. Respondent testified that his
Tennessee nursing license is on
probation, but that he has no restrictions
on his practice or on prescribing. Id. at
60.
44. Respondent testified that none of
the allegations against him from the
home health agency involved controlled
substances. Id.
45. Respondent testified that his
probation is scheduled to end in August
2020. Id. at 64; GX 4.
Analysis
Findings as to Allegations
The Government alleges that the
Respondent’s COR should be revoked
and any pending applications be denied
because the Respondent has been
excluded from all federal health care
programs, pursuant to 21 U.S.C.
824(a)(5). The Agency has held that
section 824(a)(5) authorizes the
revocation of existing registrations, as
well as the denial of applications.
Dinorah Drug Store, Inc., 61 FR 15,972
(1996); Kuen H. Chen, M.D., 58 FR
65,401 (1993).
In the adjudication of a revocation or
suspension of a DEA COR, DEA has the
burden of proving that the requirements
for such revocation or suspension are
satisfied. 21 CFR 1301.44(e) (2010).
Where the Government has sustained its
burden and made its prima facie case,
a respondent must both accept
responsibility for his actions and
demonstrate that he will not engage in
future misconduct. Patrick W. Stodola,
M.D., 74 FR 20,727, 20,734 (2009).
Acceptance of responsibility and
remedial measures are assessed in the
context of the ‘‘egregiousness of the
violations and the [DEA’s] interest in
deterring similar misconduct by [the]
Respondent in the future as well as on
the part of others.’’ David A. Ruben,
M.D., 78 FR 38,363, 38,364 (2013).
Where the Government has sustained its
burden, that registrant must present
sufficient mitigating evidence to assure
the Acting Administrator that he/she
can be entrusted with the responsibility
commensurate with such a registration.
Medicine Shoppe-Jonesborough, 73 FR
364, 387 (2008).
The burden of proof at this
administrative hearing is a
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
35343
preponderance-of-the-evidence
standard. Steadman v. SEC, 450 U.S. 91,
100–01 (1981). The Acting
Administrator’s factual findings will be
sustained on review to the extent they
are supported by ‘‘substantial
evidence.’’ Hoxie v. DEA, 419 F.3d 477,
481 (6th Cir. 2005). The Supreme Court
has defined ‘substantial evidence’ as
such relevant evidence as a reasonable
mind might accept as adequate to
support a conclusion. Consolidated
Edison Co. of New York v. National
Labor Relations Board, 305 U.S. 197,
229 (1938). While ‘‘the possibility of
drawing two inconsistent conclusions
from the evidence’’ does not limit the
Acting Administrator’s ability to find
facts on either side of the contested
issues in the case, Shatz v. U.S. Dep’t of
Justice, 873 F.2d 1089, 1092 (8th Cir.
1989); Trawick v. DEA, 861 F.2d 72, 77
(4th Cir. 1988), all ‘‘important aspect[s]
of the problem,’’ such as a respondent’s
defense or explanation that runs counter
to the Government’s evidence must be
considered. Wedgewood Vill. Pharmacy
v. DEA, 509 F.3d 541, 549 (D.C. Cir.
2007); Humphreys v. DEA, 96 F.3d 658,
663 (3rd Cir. 1996). The ultimate
disposition of the case must be in
accordance with the weight of the
evidence, not simply supported by
enough evidence to justify, if the trial
were to a jury, a refusal to direct a
verdict when the conclusion sought to
be drawn from it is one of fact for the
jury. Steadman, 450 U.S. at 99 (internal
quotation marks omitted).
Regarding the exercise of
discretionary authority, the courts have
recognized that gross deviations from
past agency precedent must be
adequately supported, Morall v. DEA,
412 F.3d 165, 183 (D.C. Cir. 2005), but
mere unevenness in application does
not, standing alone, render a particular
discretionary action unwarranted. Chein
v. DEA, 533 F.3d 828, 835 (D.C. Cir.
2008) (citing Butz v. Glover Livestock
Comm’n Co., 411 U.S. 182, 188 (1973)).
It is well-settled that since the
Administrative Law Judge has had the
opportunity to observe the demeanor
and conduct of hearing witnesses, the
factual findings set forth in this
recommended decision are entitled to
significant deference, Universal Camera
Corp. v. NLRB, 340 U.S. 474, 496 (1951),
and that this recommended decision
constitutes an important part of the
record that must be considered in the
Acting Administrator’s decision. Morall,
412 F.3d at 179. However, any
recommendations set forth herein
regarding the exercise of discretion are
by no means binding on the Acting
Administrator and do not limit the
E:\FR\FM\02JYN1.SGM
02JYN1
35344
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
exercise of that discretion. 5 U.S.C.
557(b) (2006); River Forest Pharmacy,
Inc. v. DEA, 501 F.2d 1202, 1206 (7th
Cir. 1974); Attorney General’s Manual
on the Administrative Procedure Act 8
1947).
lotter on DSK11XQN23PROD with NOTICES1
Exclusion Under 42 U.S.C. 1320a–7(a)
The Government has alleged that the
Respondent has been excluded from
participation in a program pursuant to
section 1320a–7(a) of Title 42. The
Government can meet its burden under
§ 824(a)(5) simply by advancing
evidence that the registrant has been
excluded from a federal health care
program under 42 U.S.C. 1320a–7(a).
Johnnie Melvin Turner, M.D., 67 FR
71,203 (2002); Dinorah Drug Store, Inc.,
61 FR at 15,973. The Administrator has
sanctioned registrants where the
Government introduced evidence of a
registrant/applicant’s plea agreement
and judgment, and the resulting letter of
exclusion from the U.S. Department of
Health and Human Services, Office of
Inspector General, imposing mandatory
exclusion under section 1320a–7(a). See
Richard Hauser, M.D., 83 FR 26,308
(2018).
Additionally, the Agency has
consistently held that the underlying
conviction that led to mandatory
exclusion does not need to involve
controlled substances to support a
revocation or denial. See, e.g.,
Mohammed Asgar, M.D., 83 FR 29,569
(2018); Narciso A. Reyes, M.D., 83 FR
61,678 (2018); Richard Hauser, M.D., 83
FR at 26,308; Orlando Ortega-Ortiz,
M.D., 70 FR 15,122 (2005); Juan PillotCostas, M.D., 69 FR 62,804 (2004).
However, evidence that the underlying
conviction does not relate to controlled
substances can be used in mitigation.
Mohammed Asgar, M.D., 83 FR at
29,573 (noting respondent’s conviction
‘‘did not involve the misuse of his
registration to handle controlled
substances’’); Kwan Bo Jin, M.D., 77 FR
35,021, 35,027 (2012) (showing a lack of
evidence concerning respondent’s
‘‘prescribing practices’’).[ ] *C
Government’s Burden of Proof and
Establishment of a Prima Facie Case
Based upon my review of the
allegation by the Government, it is
necessary to determine if it has met its
prima facie burden of proving the
requirements for a sanction pursuant to
21 U.S.C. 824(a).
It is clear from the stipulations, the
Government’s evidence, and the
Respondent’s position in this matter
that there is no controversy between the
parties that the Respondent was
*C Language
VerDate Sep<11>2014
omitted for clarity.
17:12 Jul 01, 2021
Jkt 253001
convicted of the underlying criminal
charge in Virginia State court, and was
subsequently mandatorily excluded
from all federal health care programs by
HHS/OIG, pursuant to 42 U.S.C. 1320a–
7(a). The Government’s evidence clearly
demonstrates the necessary elements of
proof under 21 U.S.C. 824(a)(5) and I
find that the Government has
established a prima facie case for
revocation of the Respondent’s COR and
denial of any pending applications.
Therefore, the remaining issue, and
the central focus for determination in
this matter, is whether the Respondent
has sufficiently demonstrated that he
has accepted responsibility for his
actions, has demonstrated remorse and
taken sufficient rehabilitative and
remedial steps, to demonstrate to the
Acting Administrator that he can be
entrusted to maintain his COR. Kwan Bo
Jin, M.D., 77 FR at 35,021. The Agency
must determine whether revocation is
the appropriate sanction ‘‘to protect the
public from individuals who have
misused controlled substances or their
DEA Certificate of Registration and who
have not presented sufficient mitigating
evidence to assure the Administrative
that they can be trusted with the
responsibility carried by such a
registration.’’ Jeffrey Stein, M.D., 84 FR
46,968, 46,973 (2019) (quoting Leo R.
Miller, M.D., 53 FR 21,931, 21,932
(1988)). ‘‘The Agency also looks to the
nature of the crime in determining the
likelihood of recidivism and the need
for deterrence.’’ Id. In determining
whether and to what extent a sanction
is appropriate, consideration must be
given to both the egregiousness of the
offenses established by the
Government’s evidence and the
Agency’s interest in both specific and
general deterrence. David A. Ruben,
M.D., 78 FR 38,363, 38,364, 38,385
(2013).[ ] *D
Acceptance of Responsibility and
Rehabilitative Measures
The Government’s prima facie burden
having been met, [ ] *E the Respondent
must present sufficient mitigating
evidence to assure the Administrator
that he can be entrusted with the
responsibility incumbent with such
registration. Medicine ShoppeJonesborough, 73 FR 364, 387 (2008);
Samuel S. Jackson, 72 FR 23,848, 23,853
(2007).[ ] *F
The egregiousness and extent of an
applicant’s misconduct are significant
factors in determining the appropriate
*D Analysis of public interest factors omitted for
relevance.
*E Omitted text for clarity.
*F Omitted additional public interest analysis.
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
sanction. See Jacobo Dreszer, 76 FR
19,386, 19,387–88 (2011) (explaining
that a respondent can ‘‘argue that even
though the Government has made out a
prima facie case, his conduct was not so
egregious as to warrant revocation’’);
Paul H. Volkman, 73 FR 30,630, 30,644
(2008); Gregory D. Owens, 74 FR 36,751,
36,757 n.22 (2009).
Since the discovery of the
overpayment, the Respondent has
maintained a consistent posture of
acknowledging the impropriety and
illegality of his actions, and of
cooperation with the Government in
resolving the matter.*G He has fully
accepted responsibility for his conduct,
which led to the underlying criminal
conviction, both in his criminal
prosecution, as well as in the instant
proceeding. Tr. 58, 67; FoF 37. The
Respondent testified credibly during the
hearing when asked if he accepted
responsibility for his misconduct:
‘‘Absolutely. If I could go back and fix
it, I would.’’ Tr. 58. When directly asked
by Government counsel during crossexamination if he accepted
responsibility, he stated, ‘‘absolutely.’’
Id. at 67; FoF 37. The Respondent has
further demonstrated remorse for his
crime. Tr. 67; FoF 39.
[Moreover, it is noted that
Respondent’s crime did not directly
benefit Respondent and appears to have
been a mistake that Respondent was not
aware was occurring. Even so,
Respondent did not at any point attempt
to shift the blame to anyone, he never
tried to cover up his offense or lie, and
he credibly maintained that even though
his actions were unintentional and
indirect, he was still fully responsible in
his role as the Administrator for a
mistake that happened under his watch.
Respondent credibly demonstrated
remorse, and I find that he
unequivocally accepted responsibility.
When asked how much restitution he
*G At the advice of his attorney, Respondent
entered an Alford plea of guilty to the felony
offense of false statement to Medicaid. Although
entering this type of plea could be viewed as
mitigating his actions, I do not find this to diminish
Respondent’s acceptance of responsibility in this
case. When asked if he had realized that the offense
involved knowing or willful intent, Respondent
replied that his attorney had handled the plea
negotiation and had recommended that he view the
Alford plea as a ‘‘business decision.’’ Tr. at 68–69.
With regard to his Alford plea specifically, he
stated, ‘‘my interpretation of it was essentially that
I did not personally go enter these claims, but I am
responsible for it as the administrator.’’ Id. at 50.
As such, I find that Respondent made it clear that
he was following the legal advice that his lawyer
had given him regarding a particular legal element
of his offense and that his understanding was that
he was still taking responsibility. Therefore, in spite
of Respondent’s Alford plea, I find that he
consistently and completely accepted
responsibility.
E:\FR\FM\02JYN1.SGM
02JYN1
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
lotter on DSK11XQN23PROD with NOTICES1
paid as a result of his criminal sentence,
he answered precisely to the cent. Tr.
51. When he talked about the mistake in
the billing, he corrected himself when
he initially said ‘‘we,’’ and stated
unequivocally that it was ‘‘really’’ him.
Id. 49. In a situation such as this one
that involved a mistake, it would have
been very easy for Respondent to have
shifted the blame or mitigated the
circumstances surrounding his crime,
but he unfalteringly maintained that it
was his responsibility.] *H
Additionally, Respondent has
consistently demonstrated that he has
taken the necessary steps to correct the
error. The Respondent has returned to
clinical care, and is not involved in
billing or any other administrative
responsibility. [Respondent recognized
that he should not hold a management
or administrative position and
Respondent changed his practice area.
By doing so, Respondent has made the
effort to ensure that there is no
recurrence of his mistake in the future.
I find this to be further evidence of his
acceptance of responsibility that
demonstrates that he has taken active
steps to prevent future mistakes. He also
attends a few conferences a year,
receives regulatory update mailings, and
stated that his role as adjunct faculty
‘‘forces [him] to stay current.’’ Id. at
41.] *I
Although correcting improper
behavior and practices is very important
to establish acceptance of responsibility,
conceding wrongdoing is critical to
reestablishing trust with the Agency.
Holiday CVS, L.L.C., 77 FR 62,316,
62,346 (2012); Daniel A. Glick, D.D.S.,
80 FR at 74,801. Based upon the
evidence presented, I find that the
Respondent has demonstrated the full
measure of acceptance of responsibility,
and has fully demonstrated that he is
remorseful for his actions and has taken
considerable steps to ensure that this
conduct will not be repeated.
Loss of Trust
Where the Government has sustained
its burden and established that a
registrant has committed acts
inconsistent with the public interest,
that registrant must present sufficient
mitigating evidence to assure the Acting
Administrator that he can be entrusted
with the responsibility commensurate
with such a registration. Medicine
Shoppe, 73 FR at 387.
As demonstrated by the evidence
presented in this matter, it is clear to me
that the Respondent has unequivocally
accepted responsibility for his conduct.
His underlying criminal conduct did not
relate to his handling of controlled
substances and the Government has not
alleged or demonstrated any
deficiencies by the Respondent related
to controlled substance. [ ] *J
There is no indication that the
Respondent has ever improperly
handled controlled substances or that he
represents a danger to the public. Based
upon the evidence presented, and
consistent with Jackson, Miller, and
Stein, the Respondent has clearly
demonstrated that he can be entrusted
to properly maintain his COR.
Recommendation
Considering the entire record before
me, the conduct of the hearing, and
observation of the testimony of the
witnesses presented, I find that the
Government has met its burden of proof
and has established a prima facie case
for revocation. However, [ ] *K the
evidence suggests that the Respondent
has unequivocally accepted
responsibility, is remorseful for his
conduct, has withdrawn from any
responsibilities related to billing or
other administrative duties, and has
presented convincing evidence
demonstrating that the Agency can
entrust him to maintain his COR.
Therefore, I recommend the
Respondent’s DEA Certificates of
Registration MJ3401609 and MJ4509331
should not be revoked and any pending
applications for renewal or modification
of such registration, or for additional
DEA registrations, be granted.
Signed: February 19, 2020.
Mark M. Dowd,
U.S. Administrative Law Judge
[FR Doc. 2021–14163 Filed 7–1–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
[OMB Number 1110–0045]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of
Currently Approved Collection;
Customer Satisfaction Assessment
Survey
Federal Bureau of
Investigation, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice,
Federal Bureau of Investigation,
Laboratory Division (LD) has submitted
SUMMARY:
*H Language
*J Language
*I Language
added.
added.
*K Omitted
VerDate Sep<11>2014
19:15 Jul 01, 2021
Jkt 253001
PO 00000
omitted for clarity.
text for clarity.
Frm 00087
Fmt 4703
Sfmt 4703
35345
the following Information Collection
Request to the Office of Management
and Budget (OMB) for review and
clearance in accordance with the
established review procedures of the
Paperwork Reduction Act of 1995. The
proposed information collection is
published to obtain comments from the
public and affected agencies.
DATES: The Department of Justice
encourages public comment and will
accept input until August 2, 2021.
FOR FURTHER INFORMATION CONTACT:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. The Title of the Form/Collection:
Customer Satisfaction Assessment.
3. The agency form number: FD–1000.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Respondents primarily include
federal, state, and local law
enforcement. Respondents also include
the intelligence community, Department
E:\FR\FM\02JYN1.SGM
02JYN1
Agencies
[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35339-35345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14163]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 19-22]
Keith A. Jenkins, N.P.; Decision and Order
On February 19, 2020, the Drug Enforcement Administration
(hereinafter, DEA or Government) Administrative Law Judge Mark M. Dowd
(hereinafter, ALJ), issued a Recommended Rulings, Findings of Fact,
Conclusions of Law, and Decision (hereinafter, RD) on the action to
revoke the DEA Certificate of Registration Numbers MJ3401609 and
MJ4509331 of Keith A. Jenkins, N.P. The ALJ transmitted the record to
me on March 10, 2020. Having reviewed and considered the entire
administrative record before me, I adopt the ALJ's RD with
modifications, where noted herein.\*\\A\
---------------------------------------------------------------------------
\*A\ I have made minor, nonsubstantive, grammatical changes to
the RD. Where I have made any substantive changes, omitted language
for brevity or relevance, or where I have added to or modified the
ALJ's opinion, I have bracketed the modified language and explained
the edit in a footnote marked with an asterisk and a letter in
alphabetical order.
---------------------------------------------------------------------------
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby dismiss the Order to Show Cause issued to Keith
A. Jenkins, N.P. I further order that any pending applications for
renewal of DEA Certificates of Registration MJ3401609 and MJ4509331 be
granted. This Order is effective immediately.
D. Christopher Evans,
Acting Administrator.
Paul Soeffing, Esq., for the Government
Robert W. Liles, Esq. and Meaghan K. McCormick, Esq., for the
Respondent
Recommended Rulings, Findings of Fact, Conclusions of Law, and Decision
of the Administrative Law Judge
The Assistant Administrator, Diversion Control Division, Drug
Enforcement Administration (DEA), issued an Order to Show Cause
(OSC),\1\ dated April 23, 2019, seeking to revoke the Respondent's
Certificates of Registration (COR), numbers ``MJ3401609 and MJ4509331,
pursuant to 21 U.S.C. 824(a)(5), and deny any applications for renewal
or modification of such registration and any applications for any other
DEA registrations pursuant to 21 U.S.C. 824(a)(5),'' because the
Respondent has been excluded from participation in a program pursuant
to section 1320a-7(a) of Title 42. OSC, at 1. The Respondent requested
a hearing on May 16, 2019,\2\ and prehearing proceedings were
initiated.\3\ A hearing was conducted in this matter on November 20,
2019, at the DEA Hearing Facility in Arlington, Virginia.
---------------------------------------------------------------------------
\1\ ALJ Ex. 1.
\2\ ALJ Ex. 2.
\3\ ALJ Ex. 3.
---------------------------------------------------------------------------
The issue ultimately to be adjudicated by the Acting Administrator,
with the assistance of this recommended decision, is whether the record
as a whole establishes by a preponderance of the evidence that the
Respondent's subject registration with the DEA should be revoked
pursuant to 21 U.S.C. 824(a)(5).
After carefully considering the testimony elicited at the hearing,
the admitted exhibits, the arguments of counsel, and the record as a
whole, I have set forth my recommended findings of fact and conclusions
of law below.
The Allegations
In the OSC, the Government contends that the DEA should revoke the
Respondent's DEA COR because he has been excluded from participation in
a program pursuant to section 1320a-7(a) of Title 42.
Specifically, the Government alleges the following:
1. Respondent is registered with the DEA as an MLP-nurse
practitioner in Schedules II through V under DEA Certificate of
Registration MJ3401609, at 105 Vanner Rd., Mt. Juliet, TN 37122.
Respondent is also registered with the DEA under DEA Certificate of
Registration MJ4509331, at 3909 Woodley Rd., Toledo, OH 43606, with a
mailing address of 105 Vanner Rd., Mt. Juliet, TN 37122. Respondent's
registrations both expire by their terms on December 31, 2020. Id.
Prior to the current action, Respondent's DEA Certificates of
Registration have not been the subject of disciplinary or other adverse
action by the DEA.
2. On August 7, 2017, Respondent entered an ``Alford Plea of Guilty
to a Felony'' to the offense of ``False Statement to Medicaid.'' On
August 1l, 2017, the Circuit Court of Fairfax County, Virginia entered
its sentencing Order for Respondent's offense of ``False Statement for
Payment (F)'' in violation of Va. Code Section 32.1-314(F) FRD 3337F9.
See Commonwealth of Virginia v. Keith Allen Jenkins, No. FE-2017-
0000711 (Fairfax Cty. Cir. Ct.).
3. Based on Respondent's conviction, the U.S. Department of Health
and Human Services, Office of Inspector General (``HHS/OIG''), by
letter dated February 28, 2018, mandatorily excluded Respondent from
participation in Medicare, Medicaid and all federal health care
programs for a minimum period of five years pursuant to 42 U.S.C.
1320a-7(a), effective March 20, 2018. Notwithstanding the fact that the
underlying conduct for which the Respondent was convicted had no nexus
to controlled substances, the Respondent's mandatory exclusion from
Medicare, Medicaid, and all federal health care programs by HHS/OIG
warrants revocation of the Respondent's registration pursuant to 21
U.S.C. 824(a)(5). See, e.g., Richard Hauser, M.D., 83 FR 26308 (2018).
The Hearing
Government's Opening Statement
The Government outlined its case in its Opening Statement. The
Government seeks the revocation of the Respondent's registrations
pursuant to 21 U.S.C. 824(a)(5), as the Respondent has been excluded
from a program pursuant to Sec. 1320a-7a of Title 2. Tr. 12. The
Government explained that in 2017, the Respondent entered an Alford
plea of guilty, to the felony offense of false statement to Medicaid,
in the Circuit Court of Fairfax County, Virginia. On the basis of that
conviction, in 2018, the Department of Health and Human Resources,
Office of Inspector General mandatorily excluded the Respondent from
participation in Medicare, Medicaid and all federal health care
programs pursuant to 42 U.S.C. 1320a-7(a). The Respondent's exclusion
remains in effect. Id.
Respondent's Opening Statement
In his Opening Statement, the Respondent noted he has stipulated to
all of the operative facts of the case. Id. at 13. The Respondent
conceded he was convicted as charged, he was excluded from
participation from Medicare, Medicaid and all federal health benefit
programs, as alleged. Acknowledging the evidentiary burden shift to
him, upon the prima facie showing of these facts, the Respondent argued
that his
[[Page 35340]]
Registrations should not be revoked as that would be inconsistent with
the public interest. The Respondent argued that he has accepted
responsibility for his misconduct, and further that this type of
conduct can no longer reoccur, as preventive safeguards are now in
place.
Referring to the five operative factors under Sec. 823(f), the
Respondent noted that the Respondent has the ``backing and support'' of
the state nursing boards. Id. at 14. He is knowledgeable and
experienced with respect to controlled substances. He has never been
accused of any violation, state or federal, of controlled substance
statutes. He has always complied with these statutes. Finally, there is
no evidence that any of his ``other conduct'' could be a threat to the
public safety. Thus, in balancing the five factors under Sec. 823(f),
the retention of his registrations would not be inconsistent with the
public interest. Id. at 15.
Government's Case in Chief
Before presenting witnesses, the Government offered the sworn and
notarized COR history for the Respondent, which was admitted without
objection. See GX 1. The Government otherwise presented its case in
chief through the testimony of a single witness. The Government
presented the testimony of a Diversion Investigator.
Diversion Investigator (DI)
The DI has worked for the Drug Enforcement Administration for five
and a half years and holds a Bachelor's Degree in Accounting and a
Master's Degree in Business Administration. Tr. 16-17. She has
graduated from the 12-week Basic Diversion Investigator School. Id. at
17. She has also received advanced diversion investigator training,
tactical diversion training, and asset forfeiture training. Id. at 18.
The instant investigation commenced when the DEA learned that the
Respondent's Tennessee Nursing license had been suspended by the
Tennessee Board of Nursing. Id. The DI later learned that the
Respondent had been excluded from Medicare, Medicaid and all other
federal health care programs by HHS/OIG. The DI obtained a copy of the
Respondent's Alford plea of guilty to the Virginia felony offense of
False Statement to Medicaid, a copy of the sentencing order and a copy
of the Respondent's exclusion letter by HHS/OIG. Id. at 19-22; GX 3, 4,
5. The DI verified the Respondent's exclusion by accessing the HHS
website. Tr. 23; GX 6. The DI confirmed on the HHS website the
exclusion remained active as of the day of the hearing. Tr. 24.
On cross-examination, the DI conceded the instant case did not
involve the diversion of controlled substance, nor was she aware of any
such violations by the Respondent. Id. at 24-25.
Respondent's Case in Chief
Keith A. Jenkins, N.P.
The Respondent, Keith A. Jenkins, is a licensed Advanced Practice
Registered Nurse in Tennessee and Ohio. Id. at 33; RX 1, 7. He holds
DEA registrations in Tennessee and Ohio. Tr. 33, 39-40; RX 4. Other
than this instant proceeding, the Respondent has never been disciplined
or cautioned by the DEA. Tr. 39, 61. The Respondent has never been
admonished, reprimanded or disciplined by any of the state nursing
boards regarding his prescribing practices. Id. at 61. The Respondent
has never been convicted of any offense involving controlled
substances. Id.
His educational background includes an Associate's Degree in
Medical Laboratory Technology from Cumberland College in 1997, an
Associate's Degree in Nursing in 2002, a Master's Degree in Nursing and
Adult Bariatric Nurse Practitioner in 2014, post-Master's Certificate
for Family Nurse Practitioner in 2015, and post-Master's Certificate
for Psychiatric Nurse Practitioner in 2017. Id. at 28. The Respondent
is currently working on his Doctorate, which he expects to complete by
January 2020.
The Respondent is an adjunct faculty member in a nurse practitioner
program. Id. at 28-29; RX 1. He teaches various courses, including
Pharmacology. Tr. 41. He works part-time at two clinics, a bariatric
clinic, and a primary care psychiatric clinic. Id. at 29. The
Respondent typically prescribed controlled substances, Phentermine and
Qsymia. At the psychiatric clinic, controlled substances typically
prescribed include benzodiazepines, such as Clonazepam. Other
controlled substances prescribed there include Alprazolam, Ritalin, and
Adderall. Id. at 30. The Respondent also volunteers at a free clinic
and may prescribe, on average, one opioid per month. Id. at 31, 80.
The Respondent reported taking precautions in prescribing
controlled substances, including checking the state database for
patient drug use pattern or use history. Id. at 32. Additionally, he
requires drug screens if warranted by the results of the database
inquiry, as well as randomly. To remain current with obligations
regarding prescribing controlled substances, the Respondent reported
that he attends at least two medical conferences per year, a number of
continuing education courses, and receives regulatory updates. Id. at
41, 44; RX 9, 10, 11. His adjunct faculty position also requires him to
stay current with prescribing protocol.
The Respondent's Ohio APRN includes the authority to prescribe
controlled substances. Tr. 34; RX 7. At the time of the hearing, the
Respondent's authority to prescribe in Ohio was unrestricted. However,
the Respondent's Tennessee license reflected the disciplinary action of
probation, requiring some continuing education as a result of the
Virginia state court conviction. Tr. 36; RX 8. The Respondent has
completed the required continuing education. Tr. 42-43; RX 9, 10, 11.
His Tennessee prescribing authority remained unrestricted. Tr. 36, 60.
In September 2019, despite disclosing the circumstances surrounding his
Virginia conviction, the Respondent obtained South Carolina nursing
licensure. Id. at 37-38; RX 12. He retains unrestricted prescribing
authority in South Carolina. Tr. 38.
As relates to the Respondent's underlying misconduct, the
Respondent worked for Actera Home Health from 2008-2015, as
Administrator. Id. at 45. He did not generally provide any clinical
support or prescribe medication. Id.
His employment there ended as a result of an audit by state
authorities. The mother of a child patient of the home health service
was found to be abusing medication. Id. at 46. In response to actions
by the service, the mother filed a complaint with state regulators
against the home health service, resulting in an investigation and
audit. Id. Although the investigation revealed no wrongdoing by the
service, the audit disclosed a billing discrepancy. A different child
patient was signed up for ``personal care'' services. Id. at 47, 71,
73-74. The service used an Electronic Medical Record system (EMR) to
maintain treatment records and to bill for services. The Respondent
explained that the service's EMR system could not directly bill
Medicaid, so the service used a secondary billing system to bill
Medicaid, which auto billed weekly. Id. at 48, 70. The secondary
billing system would automatically ``pull claims over'' to it from the
EMR. Id. at 48, 70-71. Services for this child were initiated and
reported in the EMR system, which automatically initiated the Medicaid
billing through the secondary billing system. Id. at 48, 71, 78. The
normal checks and balances within the home
[[Page 35341]]
health service involved squaring the care-giver service reports with
the billing. Id. at 49, 72. If the caregiver reported a cessation of
care or change in care, the billing would be ceased or adjusted to
reflect that. Id. at 78-79. However, in this case, the grandmother/
custodian refused to allow care-givers to provide any care at all. As
there were no care-giver reports generated, the billing to Medicaid
continued automatically. There were no care-giver reports to prompt the
review of that patient's billing to Medicaid, [so the audit safeguards
never caught the error.] Id. at 49, 74-76, 78. The overpayment from
Medicaid was approximately $80,000. Id. at 48. When the audit revealed
this overpayment, Medicaid audited every patient the service billed
Medicaid. No other discrepancies were discovered. Id. at 53, 78.
The Respondent entered an Alford plea of guilty to false statement
to Medicaid. Id. at 50, 52. The Respondent understood at the time of
his plea that, as Administrator of the home health service, he was
``responsible'' for the improper claims to Medicaid, despite that he
did not personally enter the claims. Id. at 50, 69. His sentence was
three years suspended, three years inactive probation, and $83,027.56
in restitution. Id. at 51-52, 63. I asked the Respondent if he
realized, at the time he plead guilty, the criminal offense of false
statement to Medicaid required the intent of intentional or willful.
The Respondent reported that his criminal attorney handled the plea
negotiation and recommended the Respondent view the guilty plea as a
``business decision.'' Id. at 68-69. [Respondent stated, ``Since they
never got a record on him, it never got caught. In hindsight, it was a
huge gap on our end or my end, really, that let that slip through.''
Id. at 49. His attorney asked, ``So whose fault was it?'' Id. ``Well,
mine.'' Id.]
Conceding the Government proved its prima facie case, the
Respondent argued that he should be permitted to keep his CORs. Id. at
57. He explained that the incident that gave rise to the felony
conviction and the resultant HHS exclusion was [``an isolated incident,
it wasn't intentional but [he does] realize that in [his] acting role
as administrator, ultimately, it is [his] responsibility.''] Id. at 58,
67. The Respondent did not have clinical duties at the service. He did
not supervise the line care providers. They were supervised by the
nursing director. Id. at 77-78. Although he had access to the billing
records in the form of an electronic report, his duties did not include
reviewing the accuracy of the billing report. Id. at 78. The accuracy
of the billing was insured by periodic audits, which failed them in
this case. Id. The Respondent did not benefit from the overpayment,\*B\
other than his salary.
---------------------------------------------------------------------------
\*B\ This fact seems to be reasonably inferred from the record.
The clinic paid restitution ``immediately once it was identified.''
Tr. 52.
---------------------------------------------------------------------------
For his Tennessee APRN, a physician supervisor is required. Id. at
59. The Respondent has a physician supervisor at each clinic where he
works. Id. at 63-64. Although supervision is required once a month, he
works closely with his physician supervisor and sees him weekly. The
supervisor critically reviews patient charts and must sign off on each
controlled substance prescription. Id. at 59. The Respondent reported
that his supervisors have yet to reject any of the Respondent's
prescriptions. Id. at 65.
The Respondent reported that he has not used his Ohio nursing
license. He has not worked in Ohio. Id. at 66.
The Respondent stated he remains fully compliant with state and
federal controlled substance laws and regulations. Id. at 61. The
Respondent noted he was an infrequent prescriber of controlled
substances. Id. The Respondent believed it is in the public interest
for him to retain his registrations.
The Facts
Stipulations of Fact
The Government and the Respondent have agreed to each of the
following stipulations, which I recommend be accepted as fact in these
proceedings:
1. Respondent is registered with the DEA as a MLP-nurse
practitioner in Schedules II through V under DEA Certificate of
Registration MJ3401609 at 105 Vanner Rd., Mt. Juliet, TN 37122.
Respondent is also registered with the DEA under DEA Certificate of
Registration MJ4509331 at 3909 Woodley Rd., Toledo, OH 43606, with a
mailing address of 105 Vanner Rd., Mt. Juliet, TN 37122. Respondent's
registrations both expire by their terms on December 31, 2020. Prior to
the current action, Respondent's DEA Certificates of Registration have
not been the subject to disciplinary or other adverse action by the
DEA.
2. From 2006 to 2013, Respondent worked in an administrative, non-
clinical, capacity for a Virginia-based home health agency. While
employed at the home health agency, the agency was audited by state
Medicaid authorities and Respondent's role in the billing of claims for
a specific patient were investigated by the state. On August 7, 2017,
Respondent entered an ``Alford Plea of Guilty to a Felony'' to the
offense of ``False Statement to Medicaid.'' On August 11, 2017, the
Circuit Court of Fairfax County, Virginia, entered its sentencing Order
for Respondent's offense of ``False Statement of Payment(F)'' in
violation of Va. Code Section 32.1-314(F) FRD3337F9. Commonwealth of
Virginia v. Keith Allen Jenkins, No. FE-2017-0000711 (Fairfax Cty. Cir.
Ct.). Mr. Jenkins was sentenced to ``3 years w/all 3 years suspended.''
Furthermore, the Court Ordered that all ``3 years [were subject to]
inactive probation.'' Simply put, Mr. Jenkins was not incarcerated, nor
is he required to report to a Probation Officer during the period of
his 3-year suspended sentence.
3. Based on Respondent's conviction, the U.S. Department of Health
and Human Services, Office of Inspector General (``HHS/OIG''), by
letter dated February 28, 2018, mandatorily excluded Respondent from
participation in Medicare, Medicaid and all federal health care
programs for a minimum period of five years pursuant to 42 U.S.C.
1320a-7(a), effective March 20, 2018.
4. Reinstatement of eligibility to participate in Medicare,
Medicaid and all federal health care programs after exclusion by HHS/
OIG is not automatic.
5. Respondent is currently excluded from participation in Medicare,
Medicaid and all federal health care programs.
6. Restitution in the amount of $83,027.56 to the Medicaid program
was ordered by the Court. The restitution was paid in full by the time
of Respondent's Alford Plea filing.
7. On April 23, 2019, the Assistant Administrator, Diversion
Control Division, DEA, issued an Order to Show Cause to Respondent,
giving Respondent notice of an opportunity to show cause why the DEA
should not revoke Respondent's DEA Certificates of Registration Nos.
MJ3401609 (Tennessee) and MJ4509331 (Ohio), pursuant to 21 U.S.C.
824(a)(5), and deny any pending application(s) as a practitioner for
registration in Schedules II through V, alleging that Respondent has
been excluded from participation in all federal health care programs as
defined in 21 U.S.C. 824(a)(5).
8. On May 16, 2019, Respondent, through his legal counsel, filed a
timely request for administrative hearing in the Matter of Keith A.
Jenkins, N.P.
9. On May 17, 2019, the Administrative Law Judge (ALJ) assigned to
this case issued the Court's Order for Prehearing Statements to the DEA
and Respondent.
10. On May 29, 2019, counsel for the Government filed the
Government's
[[Page 35342]]
Prehearing Statement. Concurrent with this filing, counsel also filed
the Government's Motion for Summary Disposition.
11. On May 30, 2019, Respondent filed an Unopposed Motion for
Extension of Time to Submit Respondent's Prehearing Statement and
Respondent's Response to the Government's Motion for Summary
Disposition.
12. On May 31, 2019, the Court issued its Order Granting
Respondent's Unopposed Motion for Extension of Time until June 21, 2019
at 2:00 p.m. EST.
13. Respondent is currently licensed by the Ohio Board of Nursing
to practice as an Advanced Practice Registered Nurse (APRN), license
number APRN.CNP.021771. The Respondent's Ohio APRN license includes the
authority to prescribe.
14. Respondent is currently licensed by the Tennessee Board of
Nursing to practice as an Advanced Practice Registered Nurse, license
no. 19606. Respondent's Tennessee APRN license is currently on
probation but is unrestricted.
15. At this time, Respondent's DEA Certificates of Registration in
Ohio and Tennessee are active and he is authorized to prescribe
controlled substances in Schedules II through V.
Findings of Fact
The factual findings below are based on a preponderance of the
evidence, including the detailed, credible, and competent testimony of
the aforementioned witnesses, the exhibits entered into evidence, and
the record before me.
1. Respondent is registered with the DEA as a MLP-nurse
practitioner in Schedules II through V under DEA Certificate of
Registration MJ3401609 at 105 Vanner Rd., Mt. Juliet, TN 37122.
Respondent is also registered with the DEA under DEA Certificate of
Registration MJ4509331 at 3909 Woodley Rd., Toledo, OH 43606, with a
mailing address of 105 Vanner Rd., Mt. Juliet, TN 37122. Stipulation
(``Stip.'') l; ALJ Ex. 13 at 10. Respondent's registrations both expire
by their terms on December 31, 2020. Id. Prior to the current action,
Respondent's DEA Certificates of Registration have not been the subject
of disciplinary or other adverse action by the DEA. Id.
2. On August 7, 2017, Respondent entered an ``Alford Plea of Guilty
to a Felony'' to the offense of ``False Statement to Medicaid.'' Stip.
2; ALJ Ex. 13 at 10. On August 11, 2017, the Circuit Court of Fairfax
County, Virginia, entered its sentencing Order for Respondent's offense
of ``False Statement for Payment (F)'' in violation of Va. Code Section
32.1-314(F) FRD3337F9. See Commonwealth of Virginia v. Keith Allen
Jenkins, No. FE-2017-0000711 (Fairfax Cty. Cir. Ct.).
3. Based on Respondent's conviction, the U.S. Department of Health
and Human Services, Office of Inspector General (``HHS/OIG''), by
letter dated February 28, 2018, mandatorily excluded Respondent from
participation in Medicare, Medicaid and all federal health care
programs for a minimum period of five years pursuant to 42 U.S.C.
1320a-7(a), effective March 20, 2018. Stip. 3; ALJ Ex. 13 at 10-11.
4. Reinstatement of eligibility to participate in Medicare,
Medicaid and all federal health care programs after exclusion by HHS/
OIG is not automatic. Stip. 4; ALJ Ex. 13 at 11.
5. Respondent is currently excluded from participation in Medicare,
Medicaid and all federal health care programs. Stip. 5; ALJ Ex. 13 at
11.
6. Restitution in the amount of $83,027.56 to the Medicaid program
was ordered by the Court. Stip. 6; ALJ Ex. 13, at 11.
7. On April 23, 2019, the Assistant Administrator, Diversion
Control Division, DEA issued an Order to Show Cause to Respondent,
giving Respondent notice of an opportunity to show cause why the DEA
should not revoke Respondent's DEA Certificates of Registration Nos.
MJ3401609 (Tennessee) and MJ4509331 (Ohio), pursuant to 21 U.S.C.
824(a)(5), and deny any pending application(s) as a practitioner for
registration in Schedules II through V, alleging that Respondent has
been excluded from participation in all federal health care programs as
defined in 21 U.S.C. 824(a)(5). Stip. 7; ALJ Ex. 13 at 11.
8. On May 16, 2019, Respondent, through his legal counsel, filed a
timely request for administrative hearing in the Matter of Keith A.
Jenkins, N.P. Stip. 8; ALJ Ex. 13 at 11.
9. On May 17, 2019, the Administrative Law Judge (ALJ) assigned to
this case issued the Court's Order for Prehearing Statements to the DEA
and Respondent. Stip. 9; ALJ Ex. 13 at 11.
10. On May 29, 2019, counsel for the Government filed the
Government's Prehearing Statement. Stip. 10; ALJ Ex. 13 at 11.
Concurrent with this filing, counsel also filed the Government's Motion
for Summary Disposition. Id.
11. Respondent is currently licensed by the Ohio Board of Nursing
to practice as an Advanced Practice Nurse (APRN), license number
APRN.CNP.021771. Stip. 13; ALJ Ex. 13 at 12.
12. The Respondent's Ohio APRN license includes authority to
prescribe. Id.
13. Respondent is currently licensed by the Tennessee Board of
Nursing to practice as an Advanced Practice Registered Nurse, license
no. 19606. Stip. 14; ALJ Ex. 13 at 12. Respondent's Tennessee APRN
license is currently on probation but is unrestricted. Id.
14. At this time, Respondent's DEA Certificates of Registration in
Ohio and Tennessee are active and he is authorized to prescribe
controlled substances in Schedules II through V. Stip. 15; ALJ Ex. 13
at 12.
15. Respondent testified that he works at a bariatric clinic where
he predominately treats morbid obesity and typically prescribes
Phentermine and Qsymia to those patients. Tr. 29.
16. He also works at a primary behavioral health clinic where he
treats depression, anxiety, schizophrenia, bipolar disorder,
personality disorders, and substance abuse disorders and prescribes
benzodiazepines such as Clonazepam and Alprazolam, as well as
stimulants such as Ritalin and Adderall. Id. at 30.
17. Respondent testified that at both the bariatric clinic and the
behavioral health practice where he works, drug screens are performed
to ensure that diversion doesn't occur. Id. at 32.
18. Respondent testified that although he holds two DEA
Certificates of Registration, he does not use his registration for
Ohio. Id. at 39.
19. Respondent testified that to remain current in his knowledge
of, and obligations with respect to, controlled substances and
prescribing he attends conferences and takes continuing education. Id.
at 41-42; RX 9; RX 11.
20. Respondent testified that from 2008 to 2015 he worked at Actera
Home Health, which was a home health agency that provided skilled care,
private duty and personal care. Tr. 45.
21. Respondent testified that he did not generally provide clinical
support at Actera Home Health, nor did he write prescriptions there.
Id.
22. Respondent testified that the mother of a child receiving
services at Actera Home Health lodged a complaint against Actera Home
Health. Id. at 46.
23. Respondent testified that the complaint was not substantiated.
Id.
24. During investigation of the complaint by the state of Virginia
a billing error was discovered for a different patient. Id. at 46, 71.
25. Respondent testified that the billing error was an overpayment
of approximately $80,000. Id. at 48.
26. Respondent testified that the service's billing checks-and-
balance
[[Page 35343]]
system failed to disclose an improper billing to Medicaid. Once the
initiation of a patient's treatment is entered into the Electronic
Medical Record (EMR), which triggers automatic billing, in this case to
Medicaid, that billing continues until a treatment report noting
cessation of treatment triggers the termination of billing. Here, the
patient's guardian refused treatment for the patient. So, no treatment
reports were ever generated and automatic billing to Medicaid
continued, despite no treatment being provided. Id. at 48, 71, 74.
27. Respondent testified that ``it was a huge gap on our end or my
end, really, that let that slip through.'' Id. at 49.
28. Respondent testified that the fault was ``mine'' and that it
was ``my responsibility.'' Id.
29. Respondent testified that he entered an Alford plea regarding
this incident. Id. at 29; GX 3.
30. Respondent testified that he entered the Alford plea because
``I did not personally go enter these claims, but I am responsible for
it as the administrator.'' Tr. 50.
31. Respondent testified that he was sentenced to three years, but
it was suspended and he served no time in jail. Id. at 51.
32. Respondent testified that he was put on probation for three
years, which remains in effect for another year. Id. at 51-52.
33. Respondent testified that the clinic paid restitution of
$83,027.67. Id. at 42; GX 3.
34. Respondent testified that his Alford plea resulted in his
conviction of a felony for a ``false statement to Medicaid.'' Tr. 52.
35. Respondent testified that he was excluded by the HHS/OIG from
Medicare and Medicaid. Id. at 54, 57; GX 5.
36. Respondent testified that his false statement to Medicaid ``was
an isolated incident,'' ``wasn't intentional'' but that as
administrator ``it is my responsibility.'' Tr. 58.
37. Respondent testified that ``[t]he Board of Nursing did not deem
me a threat to public welfare and safety'' and that he has ``no
criminal background at all with substances.'' Id.
38. Respondent testified that he ``absolutely'' accepts
responsibility for the misconduct. Id. at 58, 67.
39. Respondent testified that he considers his criminal conviction
to be a serious violation. Id. at 67.
40. Respondent testified that he is remorseful for his violation.
Id. at 58, 67.
41. Respondent testified that this violation will not happen again
because he no longer works in administrative roles, but instead
provides direct patient care and does no billing. Id. at 58.
42. Respondent testified that he also has a physician supervisor
who provides oversight. Id. at 58-59. Respondent testified that, under
Tennessee law, his physician supervisor must sign off on every
controlled substance prescription that he writes. Id. at 59, 65.
43. Respondent testified that his Tennessee nursing license is on
probation, but that he has no restrictions on his practice or on
prescribing. Id. at 60.
44. Respondent testified that none of the allegations against him
from the home health agency involved controlled substances. Id.
45. Respondent testified that his probation is scheduled to end in
August 2020. Id. at 64; GX 4.
Analysis
Findings as to Allegations
The Government alleges that the Respondent's COR should be revoked
and any pending applications be denied because the Respondent has been
excluded from all federal health care programs, pursuant to 21 U.S.C.
824(a)(5). The Agency has held that section 824(a)(5) authorizes the
revocation of existing registrations, as well as the denial of
applications. Dinorah Drug Store, Inc., 61 FR 15,972 (1996); Kuen H.
Chen, M.D., 58 FR 65,401 (1993).
In the adjudication of a revocation or suspension of a DEA COR, DEA
has the burden of proving that the requirements for such revocation or
suspension are satisfied. 21 CFR 1301.44(e) (2010). Where the
Government has sustained its burden and made its prima facie case, a
respondent must both accept responsibility for his actions and
demonstrate that he will not engage in future misconduct. Patrick W.
Stodola, M.D., 74 FR 20,727, 20,734 (2009). Acceptance of
responsibility and remedial measures are assessed in the context of the
``egregiousness of the violations and the [DEA's] interest in deterring
similar misconduct by [the] Respondent in the future as well as on the
part of others.'' David A. Ruben, M.D., 78 FR 38,363, 38,364 (2013).
Where the Government has sustained its burden, that registrant must
present sufficient mitigating evidence to assure the Acting
Administrator that he/she can be entrusted with the responsibility
commensurate with such a registration. Medicine Shoppe-Jonesborough, 73
FR 364, 387 (2008).
The burden of proof at this administrative hearing is a
preponderance-of-the-evidence standard. Steadman v. SEC, 450 U.S. 91,
100-01 (1981). The Acting Administrator's factual findings will be
sustained on review to the extent they are supported by ``substantial
evidence.'' Hoxie v. DEA, 419 F.3d 477, 481 (6th Cir. 2005). The
Supreme Court has defined `substantial evidence' as such relevant
evidence as a reasonable mind might accept as adequate to support a
conclusion. Consolidated Edison Co. of New York v. National Labor
Relations Board, 305 U.S. 197, 229 (1938). While ``the possibility of
drawing two inconsistent conclusions from the evidence'' does not limit
the Acting Administrator's ability to find facts on either side of the
contested issues in the case, Shatz v. U.S. Dep't of Justice, 873 F.2d
1089, 1092 (8th Cir. 1989); Trawick v. DEA, 861 F.2d 72, 77 (4th Cir.
1988), all ``important aspect[s] of the problem,'' such as a
respondent's defense or explanation that runs counter to the
Government's evidence must be considered. Wedgewood Vill. Pharmacy v.
DEA, 509 F.3d 541, 549 (D.C. Cir. 2007); Humphreys v. DEA, 96 F.3d 658,
663 (3rd Cir. 1996). The ultimate disposition of the case must be in
accordance with the weight of the evidence, not simply supported by
enough evidence to justify, if the trial were to a jury, a refusal to
direct a verdict when the conclusion sought to be drawn from it is one
of fact for the jury. Steadman, 450 U.S. at 99 (internal quotation
marks omitted).
Regarding the exercise of discretionary authority, the courts have
recognized that gross deviations from past agency precedent must be
adequately supported, Morall v. DEA, 412 F.3d 165, 183 (D.C. Cir.
2005), but mere unevenness in application does not, standing alone,
render a particular discretionary action unwarranted. Chein v. DEA, 533
F.3d 828, 835 (D.C. Cir. 2008) (citing Butz v. Glover Livestock Comm'n
Co., 411 U.S. 182, 188 (1973)). It is well-settled that since the
Administrative Law Judge has had the opportunity to observe the
demeanor and conduct of hearing witnesses, the factual findings set
forth in this recommended decision are entitled to significant
deference, Universal Camera Corp. v. NLRB, 340 U.S. 474, 496 (1951),
and that this recommended decision constitutes an important part of the
record that must be considered in the Acting Administrator's decision.
Morall, 412 F.3d at 179. However, any recommendations set forth herein
regarding the exercise of discretion are by no means binding on the
Acting Administrator and do not limit the
[[Page 35344]]
exercise of that discretion. 5 U.S.C. 557(b) (2006); River Forest
Pharmacy, Inc. v. DEA, 501 F.2d 1202, 1206 (7th Cir. 1974); Attorney
General's Manual on the Administrative Procedure Act 8 1947).
Exclusion Under 42 U.S.C. 1320a-7(a)
The Government has alleged that the Respondent has been excluded
from participation in a program pursuant to section 1320a-7(a) of Title
42. The Government can meet its burden under Sec. 824(a)(5) simply by
advancing evidence that the registrant has been excluded from a federal
health care program under 42 U.S.C. 1320a-7(a). Johnnie Melvin Turner,
M.D., 67 FR 71,203 (2002); Dinorah Drug Store, Inc., 61 FR at 15,973.
The Administrator has sanctioned registrants where the Government
introduced evidence of a registrant/applicant's plea agreement and
judgment, and the resulting letter of exclusion from the U.S.
Department of Health and Human Services, Office of Inspector General,
imposing mandatory exclusion under section 1320a-7(a). See Richard
Hauser, M.D., 83 FR 26,308 (2018).
Additionally, the Agency has consistently held that the underlying
conviction that led to mandatory exclusion does not need to involve
controlled substances to support a revocation or denial. See, e.g.,
Mohammed Asgar, M.D., 83 FR 29,569 (2018); Narciso A. Reyes, M.D., 83
FR 61,678 (2018); Richard Hauser, M.D., 83 FR at 26,308; Orlando
Ortega-Ortiz, M.D., 70 FR 15,122 (2005); Juan Pillot-Costas, M.D., 69
FR 62,804 (2004). However, evidence that the underlying conviction does
not relate to controlled substances can be used in mitigation. Mohammed
Asgar, M.D., 83 FR at 29,573 (noting respondent's conviction ``did not
involve the misuse of his registration to handle controlled
substances''); Kwan Bo Jin, M.D., 77 FR 35,021, 35,027 (2012) (showing
a lack of evidence concerning respondent's ``prescribing practices'').[
] \*C\
---------------------------------------------------------------------------
\*C\ Language omitted for clarity.
---------------------------------------------------------------------------
Government's Burden of Proof and Establishment of a Prima Facie Case
Based upon my review of the allegation by the Government, it is
necessary to determine if it has met its prima facie burden of proving
the requirements for a sanction pursuant to 21 U.S.C. 824(a).
It is clear from the stipulations, the Government's evidence, and
the Respondent's position in this matter that there is no controversy
between the parties that the Respondent was convicted of the underlying
criminal charge in Virginia State court, and was subsequently
mandatorily excluded from all federal health care programs by HHS/OIG,
pursuant to 42 U.S.C. 1320a-7(a). The Government's evidence clearly
demonstrates the necessary elements of proof under 21 U.S.C. 824(a)(5)
and I find that the Government has established a prima facie case for
revocation of the Respondent's COR and denial of any pending
applications.
Therefore, the remaining issue, and the central focus for
determination in this matter, is whether the Respondent has
sufficiently demonstrated that he has accepted responsibility for his
actions, has demonstrated remorse and taken sufficient rehabilitative
and remedial steps, to demonstrate to the Acting Administrator that he
can be entrusted to maintain his COR. Kwan Bo Jin, M.D., 77 FR at
35,021. The Agency must determine whether revocation is the appropriate
sanction ``to protect the public from individuals who have misused
controlled substances or their DEA Certificate of Registration and who
have not presented sufficient mitigating evidence to assure the
Administrative that they can be trusted with the responsibility carried
by such a registration.'' Jeffrey Stein, M.D., 84 FR 46,968, 46,973
(2019) (quoting Leo R. Miller, M.D., 53 FR 21,931, 21,932 (1988)).
``The Agency also looks to the nature of the crime in determining the
likelihood of recidivism and the need for deterrence.'' Id. In
determining whether and to what extent a sanction is appropriate,
consideration must be given to both the egregiousness of the offenses
established by the Government's evidence and the Agency's interest in
both specific and general deterrence. David A. Ruben, M.D., 78 FR
38,363, 38,364, 38,385 (2013).[ ] \*D\
---------------------------------------------------------------------------
\*D\ Analysis of public interest factors omitted for relevance.
---------------------------------------------------------------------------
Acceptance of Responsibility and Rehabilitative Measures
The Government's prima facie burden having been met, [ ] \*E\ the
Respondent must present sufficient mitigating evidence to assure the
Administrator that he can be entrusted with the responsibility
incumbent with such registration. Medicine Shoppe-Jonesborough, 73 FR
364, 387 (2008); Samuel S. Jackson, 72 FR 23,848, 23,853 (2007).[ ]
\*F\
---------------------------------------------------------------------------
\*E\ Omitted text for clarity.
\*F\ Omitted additional public interest analysis.
---------------------------------------------------------------------------
The egregiousness and extent of an applicant's misconduct are
significant factors in determining the appropriate sanction. See Jacobo
Dreszer, 76 FR 19,386, 19,387-88 (2011) (explaining that a respondent
can ``argue that even though the Government has made out a prima facie
case, his conduct was not so egregious as to warrant revocation'');
Paul H. Volkman, 73 FR 30,630, 30,644 (2008); Gregory D. Owens, 74 FR
36,751, 36,757 n.22 (2009).
Since the discovery of the overpayment, the Respondent has
maintained a consistent posture of acknowledging the impropriety and
illegality of his actions, and of cooperation with the Government in
resolving the matter.\*G\ He has fully accepted responsibility for his
conduct, which led to the underlying criminal conviction, both in his
criminal prosecution, as well as in the instant proceeding. Tr. 58, 67;
FoF 37. The Respondent testified credibly during the hearing when asked
if he accepted responsibility for his misconduct: ``Absolutely. If I
could go back and fix it, I would.'' Tr. 58. When directly asked by
Government counsel during cross-examination if he accepted
responsibility, he stated, ``absolutely.'' Id. at 67; FoF 37. The
Respondent has further demonstrated remorse for his crime. Tr. 67; FoF
39.
---------------------------------------------------------------------------
\*G\ At the advice of his attorney, Respondent entered an Alford
plea of guilty to the felony offense of false statement to Medicaid.
Although entering this type of plea could be viewed as mitigating
his actions, I do not find this to diminish Respondent's acceptance
of responsibility in this case. When asked if he had realized that
the offense involved knowing or willful intent, Respondent replied
that his attorney had handled the plea negotiation and had
recommended that he view the Alford plea as a ``business decision.''
Tr. at 68-69. With regard to his Alford plea specifically, he
stated, ``my interpretation of it was essentially that I did not
personally go enter these claims, but I am responsible for it as the
administrator.'' Id. at 50. As such, I find that Respondent made it
clear that he was following the legal advice that his lawyer had
given him regarding a particular legal element of his offense and
that his understanding was that he was still taking responsibility.
Therefore, in spite of Respondent's Alford plea, I find that he
consistently and completely accepted responsibility.
---------------------------------------------------------------------------
[Moreover, it is noted that Respondent's crime did not directly
benefit Respondent and appears to have been a mistake that Respondent
was not aware was occurring. Even so, Respondent did not at any point
attempt to shift the blame to anyone, he never tried to cover up his
offense or lie, and he credibly maintained that even though his actions
were unintentional and indirect, he was still fully responsible in his
role as the Administrator for a mistake that happened under his watch.
Respondent credibly demonstrated remorse, and I find that he
unequivocally accepted responsibility. When asked how much restitution
he
[[Page 35345]]
paid as a result of his criminal sentence, he answered precisely to the
cent. Tr. 51. When he talked about the mistake in the billing, he
corrected himself when he initially said ``we,'' and stated
unequivocally that it was ``really'' him. Id. 49. In a situation such
as this one that involved a mistake, it would have been very easy for
Respondent to have shifted the blame or mitigated the circumstances
surrounding his crime, but he unfalteringly maintained that it was his
responsibility.] \*H\
---------------------------------------------------------------------------
\*H\ Language added.
---------------------------------------------------------------------------
Additionally, Respondent has consistently demonstrated that he has
taken the necessary steps to correct the error. The Respondent has
returned to clinical care, and is not involved in billing or any other
administrative responsibility. [Respondent recognized that he should
not hold a management or administrative position and Respondent changed
his practice area. By doing so, Respondent has made the effort to
ensure that there is no recurrence of his mistake in the future. I find
this to be further evidence of his acceptance of responsibility that
demonstrates that he has taken active steps to prevent future mistakes.
He also attends a few conferences a year, receives regulatory update
mailings, and stated that his role as adjunct faculty ``forces [him] to
stay current.'' Id. at 41.] \*I\
---------------------------------------------------------------------------
\*I\ Language added.
---------------------------------------------------------------------------
Although correcting improper behavior and practices is very
important to establish acceptance of responsibility, conceding
wrongdoing is critical to reestablishing trust with the Agency. Holiday
CVS, L.L.C., 77 FR 62,316, 62,346 (2012); Daniel A. Glick, D.D.S., 80
FR at 74,801. Based upon the evidence presented, I find that the
Respondent has demonstrated the full measure of acceptance of
responsibility, and has fully demonstrated that he is remorseful for
his actions and has taken considerable steps to ensure that this
conduct will not be repeated.
Loss of Trust
Where the Government has sustained its burden and established that
a registrant has committed acts inconsistent with the public interest,
that registrant must present sufficient mitigating evidence to assure
the Acting Administrator that he can be entrusted with the
responsibility commensurate with such a registration. Medicine Shoppe,
73 FR at 387.
As demonstrated by the evidence presented in this matter, it is
clear to me that the Respondent has unequivocally accepted
responsibility for his conduct. His underlying criminal conduct did not
relate to his handling of controlled substances and the Government has
not alleged or demonstrated any deficiencies by the Respondent related
to controlled substance. [ ] \*J\
---------------------------------------------------------------------------
\*J\ Language omitted for clarity.
---------------------------------------------------------------------------
There is no indication that the Respondent has ever improperly
handled controlled substances or that he represents a danger to the
public. Based upon the evidence presented, and consistent with Jackson,
Miller, and Stein, the Respondent has clearly demonstrated that he can
be entrusted to properly maintain his COR.
Recommendation
Considering the entire record before me, the conduct of the
hearing, and observation of the testimony of the witnesses presented, I
find that the Government has met its burden of proof and has
established a prima facie case for revocation. However, [ ] \*K\ the
evidence suggests that the Respondent has unequivocally accepted
responsibility, is remorseful for his conduct, has withdrawn from any
responsibilities related to billing or other administrative duties, and
has presented convincing evidence demonstrating that the Agency can
entrust him to maintain his COR.
---------------------------------------------------------------------------
\*K\ Omitted text for clarity.
---------------------------------------------------------------------------
Therefore, I recommend the Respondent's DEA Certificates of
Registration MJ3401609 and MJ4509331 should not be revoked and any
pending applications for renewal or modification of such registration,
or for additional DEA registrations, be granted.
Signed: February 19, 2020.
Mark M. Dowd,
U.S. Administrative Law Judge
[FR Doc. 2021-14163 Filed 7-1-21; 8:45 am]
BILLING CODE 4410-09-P